F
Fennec Pharmaceuticals Inc. (FENC)
NCM – Real Time Price. Currency in USD
7.03
-0.07 (-0.99%)
At close: May 12, 2026, 4:00 PM EDT
7.03
0.00 (0.00%)
After-hours: May 12, 2026, 4:10 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
7.03
-0.07 (-0.99%)
At close: May 12, 2026, 4:00 PM EDT
7.03
0.00 (0.00%)
After-hours: May 12, 2026, 4:10 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 6.37 | 6.05 | 10 | |
| Quick ratio | 6.23 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | -9.00 | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 1M | 22M | 45M | 45M | 45M |
| Gross Profit | 1M | 20M | 42M | 42M | 41M |
| Operating Income | -22M | -13M | 2M | -6M | -7M |
| Net Income | -23M | -16M | -415K | -10M | -10M |
| EBITDA | -22M | -13M | 2M | -6M | -7M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 62.05 | -11.99 | 5.5 |
| Next quarter | 56.54 | 80.33 | 10 |
| Current year | 51.35 | 136.31 | 10 |
| Next year | 50.42 | 567.63 | 10 |
| Weighted average score | 8.9 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 13.53 | -727.95 | -745.9 | -615.12 | 2.8 |
| Y/Y | 81.64 | -231.97 | -183.2 | -562.29 | 3.3 |
| 3y average | 492.51 | -720.73 | 376.93 | 29.79 | 7.8 |
| 5y average | 475.31 | -436.96 | 221.58 | 16.1 | 7.5 |
| Weighted average score | 5.4 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Cash reserves $36.7M barely cover the upcoming debt maturities $0.0
Total current assets $66.9M exceed Total current liabilities $10.5M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage
Interest coverage ratio (-9.0x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$8.0M limits the company's ability to reinvest or pay down debt